Home » Topics » Disease categories and therapies » Infection

Infection
RSS

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Bayer and Novalon enter collaborative agreement to discover antiinfective drugs

Oct. 1, 1998

Potent, broad-spectrum, orally active 2-pyridone antibacterial enters Abbott pipeline

Sep. 30, 1998

Valaciclovir therapy suppresses viral shedding in patients with genital herpes

Sep. 30, 1998

SB initiates phase III trials with fluoroquinolone antibiotic

Sep. 30, 1998

Carbapenems in development at Korean research institute characterized at ICAAC

Sep. 30, 1998

SYN-2869: new triazole antifungal agent selected for further development

Sep. 30, 1998

Pyrrole antiviral agents prepared and evaluated at Rhone-Poulenc Rorer

Sep. 30, 1998

Nyotran effective against treatment-resistant fungal infections in phase II study

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...